Where can I have a Harmony NIPT Test? 

The TDL VeriSeq v2 by Illumina test (NIPT) is currently the most advanced non-invasive pregnancy screening available for parents who would like to determine if they have a low probability or high probability for their baby having the conditions Down’s syndrome, Edwards’ syndrome or Patau’s syndrome. The TDL Veriseq v2 by Illumina test is available from as early as 10 weeks of pregnancy, for early screening before the NHS Nuchal Translucency scan. NIPT can be performed after the NHS 11-14 week Nuchal Translucency Scan, or even in the mid term of pregnancy after the 20 week anomaly scan.

It has been discovered that a blood sample taken from the mother from 10 weeks of pregnancy onwards can be analysed for cell free DNA (cfDNA), which represents a sample of a sample of the fetal-placental DNA, derived from placental trophoblasts, in the mother’s blood.

The VeriSeq prenatal screening method involves taking a safe blood sample from the mother’s arm. There is no increased miscarriage risk to your baby from having this simple, safe maternal blood test. The cell free DNA (cf DNA) which is present in the mother’s blood is then analysed, the results determine if there is a high probability or low probability of the baby having one of the three screened conditions; Down’s syndrome, Edwards’ syndrome and Patau’s syndrome. These conditions are also known as Trisomy 21, Trisomy 18 and Trisomy 13.